Physician profile
Benjamin Getz
NPI 1285016923
$24,461.23
in general payments reported to CMS, 2019-2025
19 companies · $14K in 2025
The $14K reported for 2025 was more than what 97% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,751 · 2020: $208 · 2021: $3,163 · 2022: $1,409 · 2023: $622 · 2024: $3,246 · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,963 · Food and Beverage: $6,114 · Travel and Lodging: $2,853.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,962.50 |
| Food and Beverage | $6,114.15 |
| Travel and Lodging | $2,852.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $9,917.64 | 2023-2025 | |
| Bone Support INC. | $3,167.12 | 2024-2025 | Cerament G, Ceramentbone Void Filler |
| Arthrex, INC. | $2,907.11 | 2021-2024 | |
| Wardlow Enterprises | $2,700.00 | 2019-2022 | |
| Stryker Corporation | $1,898.87 | 2019-2025 | Augment Injectable, Easyfuse, Ortholoc 2 Lapifuse |
| Depuy Synthes Sales INC. | $938.45 | 2020-2025 | Hammerlock, Tfn-Advance, Na |
| Medical Device Business Services, INC. | $902.11 | 2024 | Na |
| Sanara Medtech INC. | $477.76 | 2025 | Celleraterx |
| Organogenesis INC. | $458.36 | 2019-2025 | Puraply Wound Matrix, Puraply |
| Kerecis Limited | $320.96 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Smith+Nephew, INC. | $191.03 | 2019-2025 | Stravix Pl, Grafix Pl |
| Zimmer Biomet Holdings, INC. | $167.94 | 2020-2021 | |
| Prism Medical | $142.75 | 2024 | |
| Acera Surgical, INC. | $106.88 | 2020 | |
| Medshape, INC. | $91.68 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medline Industries LP | $29.84 | 2025 | |
| Kuros Biosciences USA, INC | $22.93 | 2025 | Magnetos |
| Melinta Therapeutics, LLC | $17.78 | 2019 | |
| Aroa Biosurgery Incorporated | $2.02 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Getz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.